Mgr. Tomáš Loja, Ph.D.
Technology expert, Genomics Core Facility
office: bldg. E35/234
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 7455 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 116
2026
-
Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin
Cancer Cell International, year: 2026, volume: 26, edition: 1, DOI
2025
-
Functional characterization of 16 variants found in the LDL receptor gene
JOURNAL OF LIPID RESEARCH, year: 2025, volume: 66, edition: 9, DOI
-
Protein structure and interactions elucidated with in-cell NMR for different cell cycle phases and in 3D human tissue models
Communications Biology, year: 2025, volume: 8, edition: 1, DOI
-
Regulation of Cell-Nanoparticle Interactions through Mechanobiology
NANO LETTERS, year: 2025, volume: 25, edition: 7, DOI
2024
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
British journal of haematology, year: 2024, volume: 205, edition: 6, DOI
-
Dual Nature of MoO3 Particles in Human-Derived Macrophage Milieu
ACS Applied Nano Materials, year: 2024, volume: 7, edition: 18, DOI
-
IDENTIFICATION OF CHRONIC MYELOID LEUKEMIA STEM CELLS AT DIAGNOSIS AND EARLY FOLLOW-UP
Year: 2024, type: Conference abstract
-
In-cell NMR suggests that DNA i-motif levels are strongly depleted in living human cells
Nature Communications, year: 2024, volume: 15, edition: 1, DOI
-
Plastic response of macrophages to metal ions and nanoparticles in time mimicking metal implant body environment
Environmental Science and Pollution Research, year: 2024, volume: 31, edition: 3, DOI
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI